Prevalence, Risk Factors, and Impact on Life of Female Urinary Incontinence: An Epidemiological Survey of 9584 Women in a Region of Southeastern China.
Southern Chinese
epidemiology
female urinary incontinence
prevalence
quality of life
risk factors
Journal
Risk management and healthcare policy
ISSN: 1179-1594
Titre abrégé: Risk Manag Healthc Policy
Pays: England
ID NLM: 101566264
Informations de publication
Date de publication:
2023
2023
Historique:
received:
16
05
2023
accepted:
19
07
2023
medline:
15
8
2023
pubmed:
15
8
2023
entrez:
15
8
2023
Statut:
epublish
Résumé
To investigate the prevalence, risk factors, and impact on quality of life (QOL) of female urinary incontinence (UI) in a region of southeastern China. This cross-sectional study, conducted between June 2022 and March 2023, included 9584 women aged 20-70 years who completed a standardized questionnaire through face-to-face interviews. This sample size represents almost 10% of the population in the target area. The prevalence of female UI was found to be 24.8%, with stress UI being the most common subtype (12.7%), followed by mixed UI (8.0%) and urgency UI (4.1%). Notably, the prevalence of UI increased progressively with age and body mass index (BMI). The study also revealed several risk factors for UI, including urban residence, postmenopausal status, multiple vaginal deliveries, instrumental vaginal deliveries, previous delivery of macrosomia, and prior history of pelvic floor surgery as determined by multivariate analysis. Furthermore, the study showed that 89.5% of women who reported UI experienced varying degrees of negative impact on their QOL. The incontinence quality of life (I-QOL) scale had an average score of 79.70±19.03, which decreased with increasing severity of UI. Despite the adverse effects on QOL, only 20.6% of women with UI had sought medical help. UI is common among women in the survey area. UI has been observed to have varying degrees of adverse effects on the QOL of those affected, but most of them do not seek treatment for several reasons, highlighting the urgent need for health authorities to develop effective UI intervention strategies.
Identifiants
pubmed: 37581111
doi: 10.2147/RMHP.S421488
pii: 421488
pmc: PMC10423612
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1477-1487Informations de copyright
© 2023 Wang et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Neurourol Urodyn. 2020 Apr;39(4):1063-1086
pubmed: 32243626
Eur Urol. 2009 Jul;56(1):177-83
pubmed: 19376639
Int Urogynecol J. 2016 Jun;27(6):887-93
pubmed: 26638154
BMC Womens Health. 2021 Apr 22;21(1):172
pubmed: 33888113
Neurourol Urodyn. 2008;27(6):522-4
pubmed: 18351586
Am J Obstet Gynecol. 2021 Aug;225(2):166.e1-166.e12
pubmed: 33727114
Int J Gynaecol Obstet. 2010 Apr;109(1):55-8
pubmed: 20022321
Maturitas. 2011 Feb;68(2):137-42
pubmed: 21195563
Obstet Gynecol. 2014 Apr;123(4):822-7
pubmed: 24785611
Curr Urol Rep. 2011 Oct;12(5):358-62
pubmed: 21847532
PLoS One. 2017 Sep 14;12(9):e0183934
pubmed: 28910301
Aging Clin Exp Res. 2021 Jan;33(1):25-35
pubmed: 32964401
Eur Urol. 2006 Dec;50(6):1306-14; discussion 1314-5
pubmed: 17049716
Eur Urol. 2005 Aug;48(2):309-13
pubmed: 16005377
Eur Urol. 2007 Apr;51(4):1073-81; discussion 1081-2
pubmed: 17081676
Neurourol Urodyn. 2002;21(2):167-78
pubmed: 11857671
Asia Pac J Public Health. 2015 Mar;27(2):NP1118-31
pubmed: 22186396
Nat Rev Dis Primers. 2017 Nov 16;3:17097
pubmed: 29143807
Diabetes Metab Syndr Obes. 2015 Aug 28;8:409-13
pubmed: 26357485
BMC Urol. 2020 Oct 14;20(1):159
pubmed: 33054777
Int Urogynecol J. 2010 May;21(5):589-93
pubmed: 20179907
Int J Gynaecol Obstet. 2003 Sep;82(3):327-38
pubmed: 14499979
Urology. 1999 Jan;53(1):71-6
pubmed: 9886591
Eur Urol. 2015 Jul;68(1):97-112
pubmed: 25572826